Your browser doesn't support javascript.
loading
Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy.
Minenkova, Olga; Santapaola, Daniela; Milazzo, Ferdinando Maria; Anastasi, Anna Maria; Battistuzzi, Gianfranco; Chiapparino, Caterina; Rosi, Antonio; Gritti, Giuseppe; Borleri, Gianmaria; Rambaldi, Alessandro; Dental, Clélia; Viollet, Cécile; Pagano, Bruno; Salvini, Laura; Marra, Emanuele; Luberto, Laura; Rossi, Antonio; Riccio, Anna; Merlo Pich, Emilio; Santoro, Maria Gabriella; De Santis, Rita.
  • Minenkova O; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Santapaola D; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Milazzo FM; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Anastasi AM; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Battistuzzi G; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Chiapparino C; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Rosi A; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Gritti G; ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy.
  • Borleri G; ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy.
  • Rambaldi A; ASST Papa Giovanni XXIII, Piazza OMS, 1, 24127 Bergamo, Italy; Department of Hematology and Oncology, University of Milan, Via Festa del Perdono, 7, 20122 Milan, Italy.
  • Dental C; Texcell, Batiment Genavenir 5, Rue Pierre Fontaine 1, 91058 Evry Cedex, France.
  • Viollet C; Texcell, Batiment Genavenir 5, Rue Pierre Fontaine 1, 91058 Evry Cedex, France.
  • Pagano B; Department of Pharmacy, University of Naples Federico II, Via Domenico Montesano, 49, 80131 Naples, Italy.
  • Salvini L; Fondazione Toscana Life Sciences, Via Fiorentina, 1, 53100 Siena, Italy.
  • Marra E; Takis Srl, Via di Castel Romano, 100, 00128 Rome, Italy.
  • Luberto L; Takis Srl, Via di Castel Romano, 100, 00128 Rome, Italy.
  • Rossi A; Institute of Translational Pharmacology, CNR, Via Fosso del Cavaliere, 100, 00133 Rome, Italy.
  • Riccio A; Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy.
  • Merlo Pich E; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy.
  • Santoro MG; Institute of Translational Pharmacology, CNR, Via Fosso del Cavaliere, 100, 00133 Rome, Italy; Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica, 1, 00133 Rome, Italy.
  • De Santis R; Alfasigma SpA, Biotechnology R&D, Via Pontina Km 30.400, Pomezia, 00071 Rome, Italy. Electronic address: rita.desantis@alfasigma.com.
Mol Ther ; 30(5): 1979-1993, 2022 05 04.
Article en En | MEDLINE | ID: mdl-35167974
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article